ES Lipid Management in Patients with Endocrine Disorders Pocket Guide Guidelines Cover

Lipid Management in Patients with Endocrine Disorders GUIDELINES Pocket Guide

Approved By

Endocrine Society

Digital Subscription $4.99 Add to Cart
Print $9.95 Add to Cart
Free Sample

The digital subscription version of the Lipid Management in Patients with Endocrine Disorders GUIDELINES Pocket Guide contains all the same great information found in the physical pocket guide, and can be accessed on mobile devices and online:

  • Price: $4.99 per year
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • CPT® and ICD10 codes can be added to certain guidelines for an additional fee
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Lipid Management in Patients with Endocrine Disorders Pocket Guide is based on the latest guidelines of The Endocrine Society and was developed with their collaboration. This practical quick-reference tool contains evidence-graded recommendations for management of lipids in patients with type 1 or 2 diabetes, obesity, cardiovascular disease, hypertriglyceridemia, hypogonadism, menopause, polycystic ovary syndrome and thyroid disease.

  • Spiral-bound
  • 22 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Key Points
  • Screening and Cardiovascular Disease Risk Assessment
  • Hypertriglyceridemia
  • Type 2 Diabetes Mellitus
  • Type 1 Diabetes Mellitus
  • Obesity
  • Thyroid Disease
  • Excess Glucocorticoid
  • Screening and Cardiovascular Disease Risk Assessment
  • Polycystic Ovary Syndrome
  • Menopause And Hormonal Replacement
  • Hypogonadism and Testosterone Replacement and Abuse
  • Gender-Affirming Hormone Therapy
  • Tables
    • Lipids and Lipoproteins in Select Endocrine Disorders
    • Assessment of ASCVD Risk in Patients with Endocrine Diseases
    • Proposed Decision-Making Approach to Selective Use of CAC Measurement for Risk Prediction
    • Statins: LDL-C Reduction by Dose, and Major Drug Interactions
    • Medications for Additional LDL-C Reduction in Patients Taking Statins
    • Safety of Medications for Weight Reduction in Obesity
  • Figure
    • CVD Events per 1,000 Person-Years by Strata of CAC and LDL-C

Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. The Society works to foster a greater understanding of endocrinology amongst the general public and practitioners of complementary medical disciplines and to promote the interests of all endocrinologists at the national scientific research and health policy levels of government. The Hormone Foundation, the Society's public education affiliate, is a leading source of hormone-related health information for the public, physicians, allied health professionals and the media.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account